ripekg:evaluation/RIPEA212731D631747726 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:evidence-aggregation/RIPEA212731D631747726 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:integrity-assessment-hypothesis/RIPEA212731D631747726-human-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:integrity-assessment-hypothesis/RIPEA212731D631747726-human-1-2 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:integrity-assessment-hypothesis/RIPEA212731D631747726-human-1-3 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:integrity-assessment-hypothesis/RIPEA212731D631747726-human-2-2 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:integrity-assessment-hypothesis/RIPEA212731D631747726-human-overall |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:integrity-assessment-hypothesis/RIPEA212731D631747726-inspectai-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:integrity-assessment-hypothesis/RIPEA212731D631747726-inspectai-1-2 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:integrity-assessment-hypothesis/RIPEA212731D631747726-inspectai-1-3 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:integrity-assessment-hypothesis/RIPEA212731D631747726-inspectai-2-2 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:publication-details/RIPEA212731D631747726Single oral dose of vitamin D3 supplementation prior to in vitro fertilization and embryo transfer in normal weight women: the SUNDRO randomized controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:registry-evidence/RIPEA212731D631747726 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
rdf:type |
rdfs:Resource |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
rdf:type |
owl:Thing |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
rdf:type |
ripe:ResearchIntegrityAssessmentResearch integrity assessment |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
rdf:type |
tido:Case |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripe:assesses |
ripekg:work/10.1016%2Fj.ajog.2021.04.234Single oral dose of vitamin D3 supplementation prior to in vitro fertilization and embryo transfer in normal weight women: the SUNDRO randomized controlled trial |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:integrity-assessment-question/post-publication-notices/1.0.01.2. Does the study have an associated expression of concern or other relevant post-publication notice? |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:integrity-assessment-question/post-publication-notices/1.0.0post-publication notices |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:integrity-assessment-question/research-team-related-concerns/1.0.01.3. Do other studies by the research team highlight causes for concern? |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:integrity-assessment-question/research-team-related-concerns/1.0.0research-team-related concerns |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:integrity-assessment-question/retraction-status/1.0.01.1. Does the study have an associated retraction? |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:integrity-assessment-question/retraction-status/1.0.0retraction status |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:integrity-assessment-question/study-registration/1.0.02.2. Are there concerns relating to the timing or absence of study registration? |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:integrity-assessment-question/study-registration/1.0.0study registration |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:overall-integrity-assessment-question/1.0.0What is the overall integrity assessment of the study? |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
tido:investigates |
ripekg:overall-integrity-assessment-question/1.0.0overall integrity assessment |
ripekg:retraction-notice/24180Attractiveness of women with rectovaginal endometriosis: a case-control study |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:retraction-notice/47831Randomized, double blind placebo-controlled trial: effects of Myo-inositol on ovarian function and metabolic factors in women with PCOS |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:retraction-notice/60883Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:retraction-notice/63340Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:retraction-notice/63341Low Dose of Ethinyl Estradiol Can Reverse the Antiestrogenic Effects of Clomiphene Citrate on Endometrium |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |
ripekg:study-design-evidence/RIPEA212731D631747726 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA212731D631747726 |